Eunuchism clinical trials
The registry lists 75 studies for Eunuchism across more than 10 countries. 21 are recruiting or about to start. 61 of them are mainly about Eunuchism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Eunuchism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Clarus Therapeutics, Inc. (8) · Ferring Pharmaceuticals (4) · Lipocine Inc. (4) · University of Miami (3) · Hacettepe University (2) · Marius Pharmaceuticals (2) · Seattle Institute for Biomedical and Clinical Research (2) · Endo Pharmaceuticals (2)
What is being tested here
Drugs under test in Eunuchism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Mar 2027Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism · Phase 3 · Amneal Pharmaceuticals, LLC
- Nov 2026Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency · Seattle Institute for Biomedical and Clinical Research
- Jan 2027EndoPAT Device for Endothelial Dysfunction in ED · University of California, Irvine
- Jan 2027Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone · Seattle Institute for Biomedical and Clinical Research
- Apr 2027AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism · Varol TUNALI
- Apr 2027Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes · Jumeirah American Clinic
- Jun 2027Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men · Azurity Pharmaceuticals
- Jul 2027Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors · Indiana University
- Sep 2027Exercise Self-Efficacy, Body Composition, and Physical Activity in Men With Hypogonadism · Hacettepe University
- Sep 2027Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism · Brigham and Women's Hospital
Who these studies take
Of the 16 Eunuchism studies recruiting now, 5 (31%) set no upper age limit and 8 (50%) stop at 75 or younger. 2 (13%) take children under 18. 0 (0%) are for women only and 15 (94%) for men only; 1 (6%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 0 (0%) | 13 (81%) |
| 30 | 1 (6%) | 13 (81%) |
| 40 | 1 (6%) | 14 (88%) |
| 50 | 1 (6%) | 14 (88%) |
| 65 | 0 (0%) | 11 (69%) |
| 75 | 0 (0%) | 11 (69%) |
| 85 | 0 (0%) | 7 (44%) |
Across all 75 studies, recruiting or not: 63% stop at 75 or younger and 39% at 65; 3% take children; 0% are for women only and 99% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting2
Newly registered2
- Exercise Self-Efficacy, Body Composition, and Physical Activity in Men With HypogonadismNov 9, 2026NCT07924514
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismOct 27, 2026NCT07898072
Studies
Recruiting first, then most recently updated. Showing 50 of 75. Browse all 75 → or search them.
- Exercise Self-Efficacy, Body Composition, and Physical Activity in Men With HypogonadismRecruitingNCT079245141 country
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismRecruitingNCT06689085Phase 31 country
- Anticipated Stigma, Illness Identity, and Quality of Life in Male HypogonadismRecruitingNCT077525111 country
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceRecruitingNCT07278362Phase 41 country
- Late Subclinical Cardiovascular Disease in Testicular Cancer SurvivorsRecruitingNCT056113071 country
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismRecruitingNCT07898072Phase 31 country
- AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary HypogonadismEnrolling by invitationNCT07761546Not applicable1 country
- Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged MenRecruitingNCT074762221 country
- Pain Alleviation With Testosterone in Opioid-Induced HypogonadismRecruitingNCT04798469Phase 21 country
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteroneRecruitingNCT04049331Phase 21 country
- Testosterone Treatment in Men With Chronic Kidney DiseaseRecruitingNCT05249634Phase 21 country
- Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic HypogonadismNot yet recruitingNCT07500766Phase 2
- EndoPAT Device for Endothelial Dysfunction in EDRecruitingNCT06720597Not applicable1 country
- Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenNot yet recruitingNCT07328542Phase 41 country
- Fertility Enhancement Through Regenerative Treatment in Ovaries and TestesRecruitingNCT068413281 country
- ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung CancerRecruitingNCT065321491 country
- Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17Not yet recruitingNCT06312761Phase 1/2
- Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and HypogonadismRecruitingNCT03851627Phase 41 country
- Physical Exercise as a Sustainability Tool in Men With Dysmetabolic HypogonadismRecruitingNCT06094036Not applicable1 country
- Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed HypogonadismRecruitingNCT055411721 country
- Relationship of the Microenvironment and Male FertilityNot yet recruitingNCT047041411 country
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 11 country
- Testosterone in Bariatric PatientsCompletedNCT03721497Phase 41 country
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyActive, not recruitingNCT04301765Phase 21 country
- TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney TransplantationActive, not recruitingNCT07287800Phase 1/21 country
- Natesto Spermatogenesis RebootCompletedNCT05381831Phase 41 country
- A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCompletedNCT04456296Phase 41 country
- Salivary Testosterone in Men: Diurnal Variation and Post-Prandial ResponsesCompletedNCT043266731 country
- Calciotropic Effects After HCG Stimulation TestCompletedNCT032546411 country
- Vogelxo(R) ABPM Study in Hypogandal MenCompletedNCT04558567Phase 41 country
- Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal MenCompletedNCT04467697Phase 31 country
- The Effects of Natesto For Treatment Of HypogonadismWithdrawnNCT04717362Early Phase 1
- A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS TrialTerminatedNCT05205837Phase 41 country
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsCompletedNCT04439799Phase 41 country
- Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal MenCompletedNCT03198728Phase 31 country
- Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic MenCompletedNCT05806723Phase 41 country
- Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenStatus unknownNCT057731831 country
- Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin TherapyCompletedNCT051103911 country
- Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer PatientsStatus unknownNCT053672841 country
- Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen ParametersCompletedNCT03203681Phase 41 country
- Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging MaleCompletedNCT03282682Not applicable1 country
- The Impact of Sinopharm COVID-19 Vaccination on Male FertilityStatus unknownNCT049465651 country
- Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal MenCompletedNCT01699178Phase 32 countries
- Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal MenCompletedNCT00695110Phase 21 country
- Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal MenCompletedNCT03868059Phase 31 country
- Clomid in Men With Low Testosterone With and Without Prior TreatmentCompletedNCT01904734Phase 21 country
- D-chiroinositol Administration in Hypogonadal MalesCompletedNCT04708249Not applicable1 country
- Gonadal Function in Young to Middle Aged HIV-infected MenCompletedNCT037470031 country
- Pharmacokinetic Study to Determine Time to Steady-stateCompletedNCT00911586Phase 21 country
- Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate FormulationCompletedNCT00924612Phase 22 countries